ENG and Hepatic fibrosis: TRC105, a monoclonal antibody that binds endoglin, is being analysed in more than 20 clinical trials as an anti-angiogenic drug in different tumour types but once again, a deeper knowledge on the exact function of endoglin in liver fibrosis is needed before taking a step forward.